CTOs on the Move

Spheris

www.spheris.com

 
Spheris is a Franklin, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.spheris.com
  • 9009 Carothers Pkwy
    Franklin, TN USA 37067
  • Phone: 615.261.1500

Executives

Name Title Contact Details

Similar Companies

Health Care and Rehabilitation Services

Founded in 1967, HCRS is a non-profit, community mental health agency serving Vermonters in Windham and Windsor counties. HCRS serves over 4,000 individuals every year through its mental health, substance abuse, and developmental disabilities programs. The Agency provides a wide range of social services that support optimal mental health and functioning.

Blackline Marketing

Blackline Marketing specializes in helping clients in the hospitality, travel, restaurant, health care, business services, retail and food/beverage industries create integrated marketing solutions that increase revenues and maximize long-term customer engagement. Blackline Marketing helps clients in the areas of brand strategy, customer strategy, integrated marketing planning and people/process development. Clients include Northcott Hospitality/Houlihan`s restaurants, Caribou Coffee Company, HealthSource Solutions, ARC/Value Village Stores, Pebble Creek Golf Club and the MN Women`s Public Golf Association.

OtisMed Corporation

OtisMed Corporation is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mankato House Health Care

Mankato House Health Care is a Mankato, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.